OWKIN was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology and Gilles Wainrib, PhD, a pioneer in the field of Artificial Intelligence in biology. OWKIN passed the proof-of-concept phase and is now providing its innovative AI algorithms to several of the largest cancer centers and pharmaceutical companies in Europe and in the US. With offices in New York and Paris, we pride ourselves in building a company culture around transparency, collaboration, challenge, optimism and fun.
Our team is international, multidisciplinary with incredible talent in machine learning, medicine and business. Our data scientists are among the best in the world, with several Kaggle Masters (top global 100), a DREAM Challenge top performer, and publications in ICML, NIPS and other top scientific journals.